Nightingale Health

Short answer: several routine and a few advanced blood biomarkers are consistently linked to long-term mortality and healthy lifespan. The most useful ones are those that track metabolic health, atherosclerotic risk, inflammation, kidney/liver function, oxygen-carrying capacity, and key micronutrient deficiencies. Focus first on modifiable, well‑validated tests (glucose control, ApoB/LDL, inflammation, kidney function, A1c), then add advanced tests (LDL‑particle number, Lp(a), NMR/GlycA, cystatin C) if you want deeper risk stratification. Below is a practical, prioritized list with why each matters, typical “good” targets (approximate — individual targets vary), and how to improve results. Top priorities Hemoglobin A1c (HbA1c) and fasting glucose / fasting insulin Why: Chronic hyperglycemia and insulin resistance predict diabetes, cardiovascular disease, dementia, and higher mortality. Rough target: HbA1c in the non‑diabetic range (generally <5.7%); many healthy people target ~5.0–5.6%. Fasting glucose <100 mg/dL. Lower fasting insulin / HOMA‑IR indicates better insulin sensitivity. How to improve: weight loss, improved diet (lower refined carbs), resistance + aerobic exercise, sleep, and medications when appropriate (metformin, GLP‑1 agonists). Lipids with particle measures: ApoB, LDL‑particle number (LDL‑P), LDL‑C, non‑HDL, triglycerides, HDL Why: Atherosclerotic cardiovascular disease (the leading cause of death) is best tracked by particle burden (ApoB/LDL‑P) rather than LDL‑C alone. Rough target: ApoB <80 mg/dL (lower if high risk), LDL‑P and non‑HDL as low as your risk profile warrants (many high‑risk patients aim LDL <70 mg/dL). Triglycerides <150 mg/dL; HDL higher is usually better. How to improve: diet quality, weight loss, statins/ezetimibe/PCSK9 inhibitors as indicated, exercise, reduce refined carbs and alcohol. Important and actionable High‑sensitivity CRP (hs‑CRP) and other inflammation markers (IL‑6, GlycA) Why: Chronic low‑grade inflammation (“inflammaging”) predicts mortality, cardiovascular events, and disability. Rough target: hs‑CRP <1 mg/L is low risk; 1–3 mg/L moderate; >3 mg/L higher risk. How to improve: weight loss, exercise, smoking cessation, statins, dietary improvements; specific anti‑inflammatory drugs are used in selected cases but are not routine. Lipoprotein(a) — Lp(a) Why: Strong genetic driver of atherosclerotic and valvular disease; one‑time test is usually enough because levels are largely inherited. Rough target: ideally <30–50 nmol/L (or <30–50 mg/dL depending on units); elevated levels merit specialist input. How to improve: limited; some PCSK9 inhibitors modestly lower Lp(a); new therapies (antisense oligonucleotides) are in development. Kidney function: serum creatinine/eGFR, cystatin C, urine albumin‑to‑creatinine ratio (UACR) Why: Reduced kidney function and albuminuria strongly predict cardiovascular disease and death. Rough target: eGFR >60 mL/min/1.73m2; UACR <30 mg/g. How to improve: blood pressure control (ACEi/ARB), glycemic control, avoid nephrotoxins, treat underlying causes. Complete blood count components — hemoglobin, hematocrit, RDW (red cell distribution width), WBC Why: Low hemoglobin (anemia) and high RDW/WBC count associate with higher mortality and frailty. How to improve: identify causes (iron/B12 deficiency, chronic disease), treat appropriately. Liver enzymes and markers of fatty liver (ALT, AST, GGT, fasting triglycerides) Why: NAFLD and elevated GGT/ALT associate with metabolic disease and worse long‑term outcomes. How to improve: weight loss, exercise, treat metabolic syndrome. Useful micronutrients / endocrine markers 25‑hydroxy vitamin D Why: Very low levels associate with poor health; supplementation corrects deficiency. Typical target: 30–50 ng/mL for most adults (individualize). Vitamin B12/folate, ferritin (if indicated) Why: Deficiencies cause anemia, neuropathy, and poor functional outcomes. Thyroid tests (TSH, free T4; free T3 if symptomatic) Why: Untreated hypo/hyperthyroidism affects metabolism, cognition, and cardiovascular risk. Advanced/specialty markers (for deeper risk stratification) ApoB and LDL‑P (NMR or apoB lab) Why: Better predictors of atherosclerotic risk than LDL‑C alone. How to get it: NMR Lipoprofile (LabCorp), ApoB via Quest or LabCorp, or advanced lipid panels from specialty labs. GlycA (NMR inflammation signal), IL‑6, TNF‑alpha Why: Emerging, strong predictors of long‑term risk and frailty. Cystatin C (refined eGFR) and urine biomarkers for earlier kidney disease detection. How often to test Healthy adults: basic panels (CBC, CMP, fasting lipids, HbA1c) annually. If abnormalities or higher risk: every 3–6 months while optimizing or on therapy. One‑time tests: Lp(a) (once unless family history or therapy change), ApoB/LDL‑P if you want a better baseline. Practical next steps (what I’d recommend) Start with: fasting metabolic panel + lipid panel + HbA1c + hs‑CRP + CBC + kidney/liver tests + vitamin D. Add ApoB or NMR/LDL‑P if you want precise CV risk. If you have personal/family CVD or early CVD: add Lp(a) and consider referral to a lipid specialist. Where to get these tests (brands/services) LabCorp and Quest Diagnostics — widely available, full panels and specialty tests (ApoB, Lp(a), NMR LipoProfile via LabCorp). InsideTracker or WellnessFX — consumer‑facing platforms that combine lab testing with personalized interpretation and lifestyle recommendations. Nightingale Health — advanced NMR metabolomics (more common in Europe) for GlycA and detailed metabolite profiling. Everlywell or LetsGetChecked — convenient home sample kits for common tests (A1c, lipids, vitamin D, etc.) if you prefer at‑home draws. Local primary care or a preventive cardiology/lipid clinic — for interpretation and prescription decisions (statins, BP meds, advanced therapies). Cautions Associations ≠ causation: some markers predict risk but lowering them does not always change outcomes (interpret with clinician). Targets must be individualized by age, sex, comorbidities, and medications; very low values in older adults can sometimes be harmful. Don’t chase single numbers — focus on overall risk reduction: blood pressure control, smoking cessation, body composition, cardiorespiratory fitness, good sleep, diet, and control of diabetes/lipids. If you want, tell me your age, sex, major medical history, and any recent lab results and I’ll prioritize which tests to get and give more specific target ranges and action steps.

Mentioned in position 5 of 7

Short answer: several routine and a few advanced blood biomarkers are repeatedly linked to all‑cause mortality, cardiovascular disease, and “biological age.” For practical longevity tracking, prioritize metabolic health, lipids/atherosclerotic risk, inflammation, kidney/liver function, blood counts, and a few advanced cardiac/metabolic markers. Below I list the most important markers, why they matter, what direction is generally better, and testing options/brands to consider. High‑priority (most evidence + actionable) HbA1c and fasting glucose (and fasting insulin when available) Why: Strong predictors of diabetes, cardiovascular disease, and mortality. Insulin resistance drives many aging pathways. Direction: Lower within the normal range (avoid hypoglycemia). Aim to prevent progression to prediabetes/diabetes. Standard lipid panel plus ApoB and/or non‑HDL cholesterol Why: LDL and non‑HDL predict atherosclerotic cardiovascular disease; ApoB often outperforms LDL as a particle‑based risk measure. Direction: Lower LDL/ApoB and non‑HDL are better for CV risk; targets are individualized by risk. Lipoprotein(a) — Lp(a) Why: Genetic, independent risk factor for atherosclerotic disease and stroke; important to know because it alters treatment decisions. Direction: Lp(a) is mostly fixed genetically; knowing level informs prevention. High‑sensitivity CRP (hs‑CRP) Why: Widely validated inflammation marker predicting cardiovascular events and mortality. Direction: Lower is better. Kidney function: serum creatinine/eGFR and cystatin C, plus urine albumin:creatinine ratio (UACR) Why: Kidney function is a strong predictor of mortality; albuminuria indicates vascular damage. Direction: Higher eGFR and no albuminuria are better. Complete blood count with RDW and hemoglobin Why: Anemia and elevated RDW are robust predictors of mortality in many studies. Direction: Normal hemoglobin and lower RDW within normal limits. Liver tests, especially GGT/ALT Why: GGT and some liver enzymes associate with metabolic dysfunction, oxidative stress and mortality. Direction: Lower within the normal range. Useful / medium priority hs‑Troponin and NT‑proBNP Why: Very sensitive cardiac biomarkers; predict CV events and death even when patients are asymptomatic. Direction: Lower is better; elevations prompt cardiology workup. Inflammatory cytokines (IL‑6) and fibrinogen Why: Strong links to aging and mortality beyond CRP in research settings. Direction: Lower is better; more often used in research/advanced clinics. Vitamin D (25‑OH vitamin D) Why: Low levels associate with higher mortality and various diseases; deficiency is common and correctable. Direction: Avoid deficiency; optimal range debated — discuss with clinician. Thyroid function (TSH, free T4) Why: Both overt and subtle thyroid dysfunction affect mortality and healthspan. Ferritin, iron studies, B12, folate Why: Iron overload and deficiency, and B12 deficiency, both have health consequences. Homocysteine Why: Marker tied to vascular risk; modifiable with B vitamins in deficiency states. Advanced / research-oriented (consider if you’re doing deep longevity work) Apolipoprotein A1 / ApoB ratio, advanced lipid testing (NMR LipoProfile) Why: Detailed particle information refines risk stratification. GlycA (NMR inflammation measure) and metabolomic panels Why: Strong prognostic power in large cohorts (Nightingale Health panels are an example). Epigenetic aging clocks (DNA methylation age; e.g., TruDiagnostic) Why: Correlate with biological age and respond to interventions in some studies; still evolving. Telomere length testing (e.g., Life Length / TeloYears) Why: Mixed evidence; interesting but not yet a definitive clinical guide. Lp‑PLA2, MPO, other specialized vascular markers — center/clinic dependent. How to use these results Start with baseline panel: fasting glucose/HbA1c, fasting lipid panel + ApoB or non‑HDL, hs‑CRP, CMP (kidney/liver), CBC (with RDW), vitamin D, TSH, urine ACR. If atherosclerotic risk is a concern: add Lp(a), ApoB, NMR lipoprofile, hs‑troponin/NT‑proBNP. If you want deep profiling: consider metabolomics (Nightingale), epigenetic clocks (TruDiagnostic), or telomere testing — but treat them as research/monitoring tools, not definitive clinical decisions. What changes longevity when these are out of range Most markers reflect risk pathways you can modify: control blood sugar, lower atherogenic lipids (diet, exercise, statins/medication as indicated), reduce chronic inflammation (smoking cessation, weight loss, exercise, sleep, diet), treat vitamin deficiencies, control blood pressure, and address kidney/liver disease early. Where to get tested (brands/services) Standard clinical labs: Quest Diagnostics, LabCorp — reliable for basic and many advanced tests (Lp(a), ApoB, hs‑CRP, NMR LipoProfile via LabCorp). Hospital/health system labs: your primary care provider can order validated tests and interpret in clinical context. Longevity/wellness services: InsideTracker — combines clinical labs with lifestyle recommendations geared to performance/longevity. TruDiagnostic — focused on epigenetic aging (DNA methylation clocks). Nightingale Health — large-scale metabolomics and NMR‑based biomarker panels used in research and personalized reports. Cleveland HeartLab — advanced cardiovascular risk and inflammation testing. At‑home kits (screening, not diagnostic): Everlywell, LetsGetChecked, HealthLabs offer convenience for basic panels; abnormal results should be followed up with a clinician. Caveats and practical advice Many biomarkers are interrelated; treat the person, not a single number. Clinical context and trends over time matter more than one isolated result. Some advanced tests (epigenetic clocks, telomere length, certain metabolomics) are interesting but still emerging; use them to guide lifestyle changes rather than for diagnoses. Discuss abnormal results and treatment options with your clinician before starting supplements or medications. Frequency: baseline, then repeat annually or more often if abnormalities are present or if you start therapies. If you want, tell me your age, sex, family history (especially early heart disease), and whether you want a simple starter panel or a deep longevity profile — I can suggest a specific test list and which labs/services would be best for that plan.

Mentioned in position 5 of 9

Short answer: There’s no single “best” service for everyone — it depends on whether you want clinician-led testing, convenience (at‑home kits), deep metabolomics or epigenetic clocks, and whether you want coaching. For general longevity tracking, InsideTracker is the best all‑around membership; complementary options are Quest/Labcorp (through your doctor or direct‑order services) for clinical-grade labs, LetsGetChecked or Everlywell for convenient at‑home testing, and Chronomics/TruDiagnostic for DNA methylation (epigenetic) age tests. Why these (briefly): InsideTracker — focused on longevity and performance. Combines blood biomarkers (metabolic, inflammatory, hormones, vitamins), optional DNA integration, research‑backed recommendations, and actionable personalized nutrition/lifestyle guidance. Good if you want an integrated, longevity‑oriented program and ongoing tracking. Quest Diagnostics / Labcorp — clinical labs with the widest test menu and most reliable access to specialist assays (NMR/LDL‑P, hs‑CRP, detailed hormone panels). Use through your provider or via direct‑order portals (DirectLabs, private physician). Best for medically rigorous testing and for ordering advanced markers. LetsGetChecked / Everlywell — at‑home blood/urine kits with nurse/telehealth support. Convenient for frequent monitoring (hormones, thyroid, basic metabolic and lipid panels). Good if you need convenience and privacy rather than a full clinician program. Nightingale Health (or other metabolomics providers) — if you want high‑resolution metabolomics / NMR profiling (detailed lipid subclasses and metabolic biomarkers) that can reveal early cardiometabolic risk beyond standard lipids. Chronomics / TruDiagnostic — specialized in methylation/epigenetic clocks (biological age estimates). Useful as a complementary measure of “biological age” change over time rather than replacing blood biomarkers. What to track for longevity (recommended core markers) Glycemic control: fasting glucose, HbA1c, fasting insulin (or HOMA‑IR) Lipids: full lipid panel + apoB or LDL‑particle number (NMR) if possible Inflammation: hs‑CRP, maybe IL‑6 if available Kidney & liver: creatinine/eGFR, AST/ALT Hormones & anabolic markers: testosterone (men), estradiol (women, cycle‑aware), DHEA‑S, IGF‑1 (if you’re tracking aging interventions) Nutritional: vitamin D, B12, ferritin/iron Hematology: CBC, ferritin (iron stores) Optional advanced: NMR metabolomics (LDL‑P), ceramides, homocysteine, cystatin C Epigenetic clock or telomere test as a complementary measure of biological aging How to use these services Start with a comprehensive baseline (InsideTracker or a physician‑ordered panel via Quest/Labcorp that includes the core markers above). Repeat most blood biomarkers every 3–12 months depending on risk and interventions; do epigenetic clock testing yearly or less frequently (changes are slower). Prefer clinical lab draws for accuracy when tracking small changes. Use at‑home kits for interim checks or convenience. If you want behavior coaching, choose a service that includes certified coaches or telehealth follow‑ups (InsideTracker, LetsGetChecked offer varying levels). If you tell me your priorities (most important: price, convenience, clinical rigor, coaching, or interest in epigenetic clocks/metabolomics), I’ll recommend a single best option and a sample testing cadence.

Mentioned in position 9 of 9

How often to retest blood biomarkers depends on which biomarker, your age, health status, medications, and whether results are normal or changed by treatment or lifestyle. Below are practical, commonly used intervals and reasons, plus recommended lab services you can use. General principles Get a baseline panel once (if you don’t already have one). That helps interpret future change. Retest sooner after a treatment or major lifestyle change (medication start/change, new supplement, large weight loss, new diagnosis). If results are abnormal or you’re high-risk, test more frequently; if stable and low-risk, test less often. Always discuss frequency and interpretation with your clinician before acting. Suggested intervals for common tests Comprehensive metabolic panel (CMP: liver, kidney, electrolytes): baseline, then every 6–12 months if stable; 2–6 weeks after starting or changing meds that affect liver/kidney. Lipid panel (cholesterol, LDL, HDL, triglycerides): baseline, 4–12 weeks after starting/changing statin or major diet change, then every 6–12 months until stable, otherwise every 1–4 years for low-risk adults depending on age and guidelines. Hemoglobin A1c: every 3 months if diabetic or changing diabetes meds; every 6 months if prediabetic or not at goal; annually if stable and low risk. Fasting glucose/insulin: baseline, 3 months after major weight change or med change; frequency similar to A1c. Complete blood count (CBC): baseline, then every 6–12 months if stable; sooner (2–8 weeks) if treating anemia or a hematologic condition. Thyroid tests (TSH ± free T4): 6–8 weeks after starting or changing thyroid meds, then every 6–12 months if stable. High-sensitivity CRP (inflammation): baseline, 4–12 weeks after intervention (weight loss, smoking cessation, meds) to assess change; not useful as a daily measure. Ferritin/iron studies: 8–12 weeks after starting iron repletion; baseline and then PRN for monitoring. Vitamin D (25-OH): baseline, then 8–12 weeks after starting supplementation to confirm repletion, thereafter 6–12 months if supplementing. Testosterone (men) / estradiol (women) and reproductive hormones: baseline; 6–12 weeks after therapy changes, then every 6–12 months. PSA (men): follow clinician guidance; often discussed around ages 55–69 and then individualized — commonly checked annually or every 2–4 years depending on risk. Advanced or specialized panels (genetic risk, proteomics, metabolomics): baseline and then only as directed by specialist — these are not generally repeated frequently. Timing/fasting notes Fasting (8–12 hours) for glucose and sometimes lipid testing (although many clinics accept non-fasting lipids). Draw morning samples for hormones like cortisol and testosterone for more consistent results. Where to get tests (brands/services) Quest Diagnostics or LabCorp — widely available clinical labs accepted by doctors and insurance; good for comprehensive, physician-ordered testing. Everlywell or LetsGetChecked — convenient at-home kits for common panels (cholesterol, A1c, thyroid), good for screening and convenience but review results with a clinician. InsideTracker or WellnessFX — consumer-focused panels with lifestyle-oriented interpretation and repeat testing programs; good if you want performance/optimization guidance. Thorne/Viome — sell targeted or integrative wellness tests (vitamin D, hormones, microbiome—Viome for microbiome); useful for supplement monitoring but interpret carefully. SomaLogic or Nightingale Health — advanced proteomics/metabolomics for research or high-end personalized profiling (expensive; not routine). Additional tips After a medication change or starting a supplement, plan a check at the interval listed above (e.g., 6–8 weeks for thyroid, 8–12 weeks for vitamin D). Keep a record of testing dates and results so trends are visible. If you use a direct-to-consumer lab kit, consider having abnormal or borderline results repeated at a clinical lab (Quest/LabCorp) and reviewed by your clinician. Discuss frequency with your primary care provider — they’ll tailor it to your risk profile and insurance considerations. If you tell me which specific biomarkers you’re tracking, your age and health conditions (or medications), I can give a tailored retesting schedule and suggest the best service for those tests.

Mentioned in position 10 of 10

Short answer: focus first on markers of cardiovascular health, metabolic (glucose/insulin) control, systemic inflammation, kidney/liver function, key hormones and micronutrients, and (optionally) advanced aging assays (NMR metabolomics, ApoB/LDL‑particle, epigenetic clocks). Those categories predict most of the disease burden that shortens lifespan and are actionable. What matters (prioritized) Lipids and atherogenic particle burden Tests: LDL‑C, HDL, triglycerides, ApoB, LDL‑particle number (LDL‑P) or NMR LipoProfile, Lp(a) Why: cardiovascular disease is the biggest driver of mortality; ApoB and LDL‑P often predict risk better than LDL‑C alone. Lp(a) is an independent genetic risk factor. Rough targets: LDL‑C <100 mg/dL for general prevention; <70 mg/dL if high risk. ApoB <80 mg/dL desirable. Lp(a) <50 mg/dL (or <125 nmol/L). Glycemic control / insulin resistance Tests: fasting glucose, fasting insulin, HbA1c, HOMA‑IR (from glucose + insulin) Why: diabetes and insulin resistance accelerate vascular disease, cancer risk, and functional decline. Targets: fasting glucose <100 mg/dL, HbA1c <5.7% (optimal individualized — lower within normal range is better without hypoglycemia). Keep fasting insulin low (many aim <8–10 μU/mL). Systemic inflammation Tests: hs‑CRP, optionally IL‑6 or GlycA (NMR) Why: chronic low‑grade inflammation predicts frailty, CVD, dementia and mortality. Targets: hs‑CRP <1 mg/L best; 1–3 mg/L moderate; >3 high. Kidney and liver function Tests: serum creatinine + eGFR, cystatin C (optional), urine albumin:creatinine ratio; ALT/AST, GGT, bilirubin Why: kidney/liver dysfunction shorten healthy lifespan and influence medication choice. Targets: eGFR >60 (ideally >90), ACR <30 mg/g, low/normal transaminases. Hematology and iron Tests: CBC (hemoglobin, hematocrit, RDW), ferritin, transferrin saturation Why: anemia and high RDW predict morbidity; iron overload (high ferritin/transferrin sat) links to worse outcomes in some studies. Targets: hemoglobin in normal range; avoid very high ferritin (context dependent). Hormones relevant to aging and function Tests: total/free testosterone (men), estradiol (women, as indicated), SHBG, IGF‑1 (contextual) Why: maintain muscle, bone, function; extremes (too low or too high) have risks. Targets: keep in normal, age‑appropriate ranges and treat symptoms, not numbers alone. Micronutrients and lifestyle biomarkers Tests: 25‑OH vitamin D, B12, folate, magnesium (if indicated), Omega‑3 index Why: deficiencies impair health; higher omega‑3 index associates with lower mortality. Targets: vitamin D 25‑OH ~30–50 ng/mL; omega‑3 index >8% optimal. Markers of cardiac stress Tests: NT‑proBNP (useful if cardiac disease suspected) Why: predicts heart failure and mortality. Optional/advanced tests (good if you want deeper risk profiling) NMR metabolomics (GlycA, lipoprotein particle sizes) — Nightingale Health or LabCorp NMR LipoProfile. ApoB/LDL‑P (if available) — LabCorp/Quest offer or NMR. Epigenetic clocks / DNA methylation biological age — TruDiagnostic is a major provider; gives a “biological age” estimate (useful for tracking interventions but still emerging). Telomere length tests and some specialty nutrient panels (SpectraCell) — interpret cautiously; not yet definitive for actionable clinical decisions. Practical testing sources and why LabCorp and Quest Diagnostics — wide test menus, physician‑ordered, include ApoB, advanced lipid panels, and routine labs. InsideTracker (or WellnessFX / WellnessFX merged offerings) — good if you want interpretation + personalized lifestyle recommendations based on labs; can order labs through them or upload LabCorp/Quest results. OmegaQuant — clinically validated Omega‑3 Index testing. TruDiagnostic — one of the more established epigenetic clock (DNA methylation age) services if you want a molecular aging metric. Nightingale Health (Europe) / LabCorp NMR LipoProfile — for NMR metabolomics and GlycA (inflammation + lipoprotein particle details). Everlywell / LetsGetChecked — direct‑to‑consumer home kits for some basic tests (convenient but limited panels; follow up with clinician for interpretation). What to do with the results (brief) If lipids are high → lifestyle first (diet, exercise, weight loss, smoking cessation); statin therapy under physician guidance if still elevated or high calculated risk. If glucose/insulin elevated → weight loss, carb quality control, regular exercise; consider metformin for prediabetes only with clinician discussion. If hs‑CRP elevated → search for causes (obesity, infections, periodontitis), improve sleep/activity/diet; consider anti‑inflammatory strategies under guidance. Correct vitamin D / B12 deficiency, raise omega‑3 index with fatty fish or fish oil if low. Manage high ferritin/transferrin saturation (evaluate for hemochromatosis; phlebotomy if indicated). Testing cadence Baseline full panel annually for most healthy adults; more often (every 3–6 months) if you’re changing meds, treating abnormal results, or using aggressive interventions. Advanced/epigenetic tests: every 6–12 months if used to track interventions (they can be more expensive). Caveats Individualization matters: targets depend on age, sex, clinical history and personal risk. For example, very low LDL in very old people may not always be appropriate without context. Some advanced biomarkers (telomere length, epigenetic clocks) are informative but still emerging — don’t base major medical decisions on them alone. Genetic markers (e.g., Lp(a)) are largely nonmodifiable; they change how aggressively you manage modifiable risks. If you want, tell me: your age, sex, major medical history, and whether you’re already on meds (statin, metformin, etc.), and I’ll give a focused list of the highest‑priority labs for you and target ranges to aim for.

Mentioned in position 1 of 10

Short answer: there’s no single “longevity” blood test. But several routinely measured biomarkers are strongly tied to long-term mortality and age-related disease risk — and they’re actionable. Below I list the highest‑value markers, what they indicate, rough “good” targets used in longevity medicine, how often to check them, and a few reputable labs/services you can use. Highest‑value biomarkers (why they matter and practical targets) Lipids / atherosclerosis risk LDL‑cholesterol (and non‑HDL): main driver of atherosclerotic cardiovascular disease. Lower is usually better for longevity. Practical targets: LDL <100 mg/dL for most people; <70 mg/dL if high risk. Non‑HDL <130 mg/dL. Apolipoprotein B (ApoB): better predictor than LDL mass for particle number. ApoB <80 mg/dL is commonly used as a target. Lipoprotein(a) [Lp(a)]: genetically determined risk factor — high Lp(a) markedly raises CVD risk; measured once to know baseline. Glycemia / metabolic health HbA1c: long‑term glucose control. Higher levels predict diabetes and vascular disease. Aim <5.7% for normal; many longevity clinicians prefer <5.5% if safe. Fasting glucose, fasting insulin, HOMA‑IR: help catch insulin resistance earlier than A1c. Inflammation & immune activation High‑sensitivity CRP (hs‑CRP): a robust predictor of cardiovascular events and mortality. Desirable <1 mg/L; 1–3 moderate; >3 high. (Research/optional) IL‑6 and TNFα are informative but less available clinically. Kidney & filtration markers Serum creatinine / eGFR: chronic kidney disease increases mortality risk. Cystatin C: more sensitive eGFR marker in some people and useful for combined eGFR equations. Urine albumin/creatinine ratio: early kidney damage predictor. Liver health / metabolic stress ALT, AST, GGT: elevated GGT especially correlates with metabolic disease and mortality risk. Hematology & frailty signals Complete blood count (CBC), especially hemoglobin and RDW (red cell distribution width). High RDW consistently predicts higher mortality and frailty. Cardiac stress NT‑proBNP or BNP: sensitive for occult heart strain/failure and predictive of outcomes even at “low” elevations. Nutrition / modifiable deficiencies 25‑hydroxy vitamin D (target commonly 30–50 ng/mL), B12, ferritin (iron stores) — extremes relate to poor outcomes. Thyroid TSH (with free T4/free T3 as needed): both low and high thyroid function affect aging/metabolism. Coagulation markers (in some situations) D‑dimer, fibrinogen: higher levels associate with clotting risk and mortality in older adults. Advanced/optional markers for a deeper view ApoB particle count, advanced lipoprotein testing. Lp‑PLA2, lipoprotein subfractions. Telomere length and epigenetic clocks (DNAm GrimAge, Horvath clocks): give a biological‑aging estimate (research/interpretive, not diagnostic). Proteomics/metabolomics (e.g., SomaLogic, Nightingale) can predict risk decades ahead but are mainly for research/precision programs. Which tests and services to use (reputable options) Clinical labs (standard, clinician‑grade) Quest Diagnostics and Labcorp — broad menu (lipids, ApoB, hs‑CRP, HbA1c, cystatin C, NT‑proBNP, vitamins). Your local hospital/academic center for specialty tests and nephrology/cardiology follow‑up. Consumer/precision wellness services (good for integrated interpretation) InsideTracker — aggregates labs, gives personalized targets and lifestyle interventions. Thorne WellConnect — at‑home sample kits tied to practitioners and actionable plans. Everlywell / LetsGetChecked — convenient at‑home collection for core panels, but verify what’s included. Advanced aging / research‑grade tests TruDiagnostic (epigenetic clocks), Life Length / TeloYears (telomere length), and SomaLogic or Nightingale Health for proteomics/metabolomics. How often to test Baseline: get a comprehensive baseline (CBC, CMP, lipid panel + ApoB/Lp(a), hs‑CRP, HbA1c, fasting glucose+insulin, vitamin D, TSH, urine albumin). Routine: annually for most healthy adults; every 3–6 months if you’re changing therapy (statins, weight loss, glucose management) or if abnormalities exist. Advanced tests (epigenetic/proteomic): once yearly or as recommended by the testing service — they’re best used to track trends over time. What to do with abnormal results Most of these markers are modifiable: diet (Mediterranean/plant‑forward), exercise (aerobic + resistance), sleep, smoking cessation, weight loss, and blood‑pressure control lower risk across markers. Medications (e.g., statins, antihypertensives, metformin) can be highly effective where appropriate — discuss with a clinician. Recheck after lifestyle changes or treatment adjustments to confirm improvement. Caveats Biomarkers are risk indicators, not guarantees. They must be interpreted in context (age, sex, family history, medications). Some advanced tests are still research-focused and add cost without clear, evidence‑based interventions. Always review results with a qualified clinician before starting or stopping medications. If you want, I can: Suggest a single “starter” lab panel you can order now (exact test names and typical targets), or Recommend which advanced test(s) make sense given your age, family history, and current health.

Mentioned in position 11 of 11